6-[[(1,1-dimethylethoxy)carbonyl]amino]-5-methyl-2-[[(1R)-phenylethyl]amino]-4H-3,1-benzoxazin-4-one | 185687-25-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 6-[[(1,1-dimethylethoxy)carbonyl]amino]-5-methyl-2-[[(1R)-phenylethyl]amino]-4H-3,1-benzoxazin-4-one
• 英文别名: [5-Methyl-4-oxo-2-(1-phenyl-ethylamino)-4H-benzo[d][1,3]oxazin-6-yl]-carbamic acid tert-butyl ester；tert-butyl N-[5-methyl-4-oxo-2-[[(1R)-1-phenylethyl]amino]-3,1-benzoxazin-6-yl]carbamate
• CAS: 185687-25-6
• 化学式: C₂₂H₂₅N₃O₄
• 分子量: 395.458
• InChiKey: OZYJDHXKMVNNPB-CQSZACIVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  89
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  6-[[(1,1-dimethylethoxy)carbonyl]amino]-5-methyl-2-[[(1R)-phenylethyl]amino]-4H-3,1-benzoxazin-4-one 在 盐酸 作用下， 以 乙酸乙酯 为溶剂， 生成 6-amino-5-methyl-2-[[(1R)-phenylethyl]amino]-4H-3,1-benzoxazin-4-one
  参考文献：
  名称：

  Inhibition of human cytomegalovirus protease by benzoxazinones and evidence of antiviral activity in cell culture

  摘要：

  A series of 2-amino substituted benzoxazinones were prepared that potently inhibit human cytomegalovirus protease in vitro. Selected compounds demonstrate antiviral activity in cell culture, selectivity relative to chymotrypsin and elastase and stability with respect to hydrolysis in human plasma. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00368-5
• 作为产物：
  描述：

  5-methyl-6-nitro-2H-benzo[d][1,3]oxazine-2,4(1H)-dione 在 palladium on activated charcoal 4-二甲氨基吡啶 、 sodium hydroxide 、 氢气 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 三乙胺 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 生成 6-[[(1,1-dimethylethoxy)carbonyl]amino]-5-methyl-2-[[(1R)-phenylethyl]amino]-4H-3,1-benzoxazin-4-one
  参考文献：
  名称：

  Inhibition of human cytomegalovirus protease by benzoxazinones and evidence of antiviral activity in cell culture

  摘要：

  A series of 2-amino substituted benzoxazinones were prepared that potently inhibit human cytomegalovirus protease in vitro. Selected compounds demonstrate antiviral activity in cell culture, selectivity relative to chymotrypsin and elastase and stability with respect to hydrolysis in human plasma. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00368-5

文献信息

• 2-Amino-benzoxazinones for the treatment of viral infections
  申请人：G.D. Searle & Co.

  公开号：US20030022895A1

  公开（公告）日：2003-01-30

  A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by Formula I 1 wherein R-R 4 are as defined herein, or a pharmaceutically-acceptable salt thereof.

  一类用于治疗病毒感染的化合物。特别感兴趣的化合物由公式I1定义，其中R-R4如此定义，或其药学上可接受的盐。
• 2-amino-benzoxazinones for the treatment of viral infections
  申请人：Abood Norman

  公开号：US20050032793A1

  公开（公告）日：2005-02-10

  A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by Formula I wherein R-R 4 are as defined herein, or a pharmaceutically-acceptable salt thereof.

  一类用于治疗病毒感染的化合物。特别感兴趣的化合物由公式I定义，其中R-R4如此处所定义，或其药学上可接受的盐。
• [EN] 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS<br/>[FR] 2-AMINO-BENZOXAZINONES DESTINES AU TRAITEMENT D'INFECTIONS VIRALES
  申请人：G.D. SEARLE & CO.

  公开号：WO1996037485A1

  公开（公告）日：1996-11-28

  (EN) A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by formula (I) wherein R - R4 are as defined herein, or a pharmaceutically-acceptable salt thereof.(FR) Classe de composés destinés au traitement d'infections virales. Des composés présentant un intérêt particulier sont définis par la formule (I) dans laquelle R - R4 ont la définition figurant dans la description, ou bien un sel pharmaceutiquement acceptable de ceux-ci.

  这是一种用于治疗病毒性感染类化合物。特别感兴趣的是由公式(I)定义的化合物，其中R-R4的定义参见此处描述，或非药理上可接受的盐。
• Solution-phase parallel synthesis of a benzoxazinone library using complementary molecular reactivity and molecular recognition (CMR/R) purification technology
  作者：John J. Parlow、Daniel L. Flynn

  DOI：10.1016/s0040-4020(98)00132-x

  日期：1998.4

  A solution-phase synthesis of a benzoxazinone library is described. The five-step synthesis is accomplished using combinations of complementary molecular reactivity and molecular recognition (CMR/R) purification concepts, including reactant-sequestering resins, reagent-sequestering resins, sequestration-enabling-reagents, reaction-quenching resins, as well as the judicious use of polymeric reagents. The multi-step synthesis affords the desired benzoxazinone products in excellent purities and yields. This study demonstrates that multi-step library syntheses can be performed in solution-phase, and that utilization of CMR/R purification strategies as the sole method of purification can lead to products of high purity. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
• 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS
  申请人：G.D. SEARLE & CO.

  公开号：EP0828721B1

  公开（公告）日：2001-11-14